Financials
Financial year 2025
APOTEEK DE SMEDT from Asse, company number BE0414478228, closed financial year 2025 with a result of € 12,367 after tax. For that financial year APOTEEK DE SMEDT recorded a gross margin of € 225,494 and equity of € 126,967. Compared with financial year 2024, the result moved from € -44,237 to € 12,367. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 28, 2025.
€ 126,967
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 12,367
▲ still € 44,237 loss in 2024
Profit after tax over the fiscal year.
€ 52,333
▼ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 64,967.
People and assets in 2025
2.9
Average over the fiscal year, from the social balance sheet.
€ 167,174
▲ 11% vs 2024
€ 57,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,478
▼ 30% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 78,139
▼ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,056
▲ 42% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 164,532 | € 143,740 | € 145,606 | € 225,494 | ▲ 55% |
| Profit after taxes | € 39,358 | € -38,888 | € -44,237 | € 12,367 | ▲ € 56,603 |
| Equity | € 197,725 | € 158,837 | € 114,600 | € 126,967 | ▲ 11% |
| Total debts | € 67,175 | € 193,635 | € 241,465 | € 205,949 | ▼ 15% |
| Cash | € 86,606 | € 54,708 | € 53,230 | € 52,333 | ▼ 2% |
| Retained profit | € 135,725 | € 96,837 | € 52,600 | € 64,967 | ▲ 24% |
| Balance sheet total | € 264,899 | € 352,472 | € 356,065 | € 332,915 | ▼ 7% |
| Employees (FTE) | 2.7 | 2.9 | 2.9 | 2.9 |
Key figures of APOTEEK DE SMEDT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to APOTEEK DE SMEDT?
What happened at APOTEEK DE SMEDT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 12,367. Source: NBB ↗
- Evi Pessemiers became a director. NBB
- Frevan NV became a director. NBB
- New establishment in Asse. KBO
- Start of the company according to the CBE. KBO
In short
From € 39,358 profit in 2022 to € 12,367 profit in 2025.
Paid € 718 in corporate taxes since 2022.
Best year ever: 2022, with € 39,358 profit.
On average € 77,800 of value added per employee in 2025.
A new publication or filing at APOTEEK DE SMEDT? We notify you, reason included.
Follow APOTEEK DE SMEDTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of FREVAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTEEK DE SMEDTBehind APOTEEK DE SMEDT are Frevan NV and Evi Pessemiers. The shares are held by FREVAN (98%).
Establishments
Establishment units
Physical locations of this company
St.-Hubertusplein 9
1730 Asse
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
UPCLOUD, FI
Website info
Features
Security
Network
Details
- Company number
- 0414.478.228
- VAT number
- BE 0414.478.228
- Registered office
- St.-Hubertusplein 9, 1730 Asse
- Names & denominations
- APOTEEK DE SMEDT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 September 1974
- Peppol
- Active · Active since 30 Jan 2025
- Contact
- apotheekdesmedtasse.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers